France Defibrillators Market Size, Share, and COVID-19 Impact Analysis, By Product (EDs, Implantable Cardioverter Defibrillators (ICDs)), By End-use (Hospital, Public Access Market, Alternate Care Market), and France Defibrillators Market Insights, Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Jun 2025
REPORT ID SI12057
PAGES 150
REPORT FORMAT PathSoft

France Defibrillators Market Insights Forecasts to 2035 

  • The France Defibrillators Market Size was estimated at USD 336.8 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 8.19% from 2025 to 2035
  • The France Defibrillators Market Size is Expected to Reach USD 800.6 Million by 2035

France Defibrillators Market

Get more details on this report -

Request Free Sample PDF

According to a Research Report Published by Spherical Insights & Consulting, the France Defibrillators Market Size is Anticipated to Reach USD 800.6 Million by 2035, Growing at a CAGR of 8.19% from 2025 to 2035. Some of the main factors driving industry growth include increased product development activities, an increase in the incidence of sudden cardiac arrest, public awareness, and supportive initiatives from governments and healthcare organizations.

 

Market Overview 

The France defibrillator market is also the supply and demand for devices that provide electrical shocks to return patients suffering cardiac arrest or lethal arrhythmias to a normal rhythm. The defibrillator market includes all types, such as external automated defibrillators (AEDs), implantable cardioverter defibrillators (ICDs), and wearable cardioverter defibrillators (WCDs). The rising occurrence of unexpected cardiac arrest, increasing engagement in product development activities, the growing awareness levels from the general public, and supportive actions from governments & healthcare organizations are a few of the many driving factors for the growth of the industry. Another important consideration, that is likely to influence growth in the market, is the growing senior’s population around the nation and advances in technology. The elderly population, especially those 65 years and older, generally has higher incidences of chronic diseases, mostly of which are cardiovascular diseases (CVDs). Disruption of normal heart rhythms often requires defibrillator placement to restore normal heart rhythm by delivering an electric shock to the heart.

 

Report Coverage

This research report categorizes the market for the France defibrillators market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France defibrillators market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France defibrillators market. 

 

France Defibrillators Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 336.8 Million
Forecast Period:2024-2035
Forecast Period CAGR 2024-2035 :8.19%
2035 Value Projection:USD 800.6 Million
Historical Data for:2020-2023
No. of Pages:150
Tables, Charts & Figures:110
Segments covered:By Product, By End-use and COVID-19 Impact Analysis.
Companies covered:: MicroPort Scientific Corporation, Medtronic, Koninklijke Philips N.V., Schiller AG, ZOLL Medical Corporation (Asahi Kasei), BIOTRONIK SE & Co. KG, Abbott, Boston Scientific Corporation and Others.
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The France market for defibrillators is being driven by numerous reasons, such as increasing rates of sudden cardiac arrest, increasing awareness and adoption of AEDs (automated external defibrillators), and government initiatives to increase public access to devices.  In addition to these factors, the market growth is likely to be aided by software improvements in defibrillators, increased rates of cardiovascular diseases (in the elderly population), maintenance/repair, and growth in commercial, government, and non-governmental sectors.

 

Restraining Factors

The French defibrillator market is facing challenges regarding costs (particularly for expensive devices such as ICDs) and a lack of public awareness of sudden cardiac arrest (SCA) and the role of defibrillation. Strict regulations and compliance requirements for continually evolving standards can also be a burden for producers. 

 

Market Segmentation

The France defibrillators market share is classified into product and end-use.

 

  • The implantable cardioverter defibrillators (ICDs) segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France defibrillators market is segmented by product into EDS, implantable cardioverter defibrillators (ICDs). Among these, the implantable cardioverter defibrillators (ICDs) segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. The high prevalence of CVDs, the large geriatric population in important markets, and the increasing product advancements by large corporations are the main factors propelling this segment's growth.

 

  • The hospital segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France defibrillators market is segmented by end-use into hospital, public access market, and alternate care market. Among these, the hospital segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to the increased number of cardiac procedures and cases that take place in hospitals. In hospitals, both external defibrillators and ICDs are frequently used to treat patients experiencing sudden cardiac arrest as well as for other purposes.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France defibrillators market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • MicroPort Scientific Corporation
  • Medtronic
  • Koninklijke Philips N.V.
  • Schiller AG
  • ZOLL Medical Corporation (Asahi Kasei)
  • BIOTRONIK SE & Co. KG
  • Abbott
  • Boston Scientific Corporation
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France Defibrillators Market based on the below-mentioned segments:

 

France Defibrillators Market, By Product                                                  

  • EDs
  • Implantable Cardioverter Defibrillators (ICDs)

 

France Defibrillators Market, By End-use                                                 

  • Hospital
  • Public Access Market
  • Alternate Care Market

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies